Abivax (ABVX.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | |||
| Depreciation Amortization | 245 | 365 | 211 |
| Accounts receivable | -2,658 | 4,700 | -677 |
| Accounts payable and accrued liabilities | 13,666 | -22,478 | 5,199 |
| Other Working Capital | 10,284 | -16,966 | 3,921 |
| Other Operating Activity | -56,920 | -16,042 | -43,408 |
| Operating Cash Flow | $-35,383 | $-50,421 | $-34,754 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -311 | -224 | -12 |
| Purchase Of Investment | N/A | N/A | -542 |
| Other Investing Activity | 2,059 | 11,781 | 2,455 |
| Investing Cash Flow | $1,748 | $11,557 | $1,901 |
| Cash Flows From Financing Activities | |||
| Debt Issued | -600 | 23,919 | 24,625 |
| Debt Repayment | -2,314 | -3,571 | -2,331 |
| Other Financing Activity | -3,375 | -1,227 | -1,093 |
| Financing Cash Flow | $-6,289 | $19,121 | $21,201 |
| Exchange Rate Effect | -1,941 | 451 | 1,319 |
| Beginning Cash Position | 222,317 | 241,608 | 251,942 |
| End Cash Position | 180,451 | 222,317 | 241,608 |
| Net Cash Flow | $-39,925 | $-19,742 | $-11,653 |
| Free Cash Flow | |||
| Operating Cash Flow | -35,383 | -50,421 | -34,754 |
| Capital Expenditure | -311 | -227 | -12 |
| Free Cash Flow | -35,694 | -50,648 | -34,766 |